trial

Transcranial Magnetic Stimulation for "Voices"

NCTId NCT00308997
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase 2 · Completed
Enrollment 85 (actual)
Sponsored by Yale University
Primary completion 2011-09
Synthesized from structured facts only — each point cited above.

Design & status

Phase
Phase 2
Status
Completed
Enrollment
85 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Triple
Start
2006-02
Primary completion
2011-09
Eligibility
ALL · 18 Years · 55 Years

Interventions & indications

Drugs
1-hertz Repetitive Transcranial Magnetic StimulationActive 1-Hertz Repetitive transcranial magnetic stimulation

Sponsors

Yale UniversityLead Sponsor
National Institute of Mental Health (NIMH)Collaborator

Investigators

1
Ralph E. Hoffman, MDPrincipal Investigator

Sites

1 total
New Haven, United States

Linked catalysts

1
Transcranial Magnetic Stimulation for "Voices" — primary completion2011-09

Facts & assertions

4 sourced
Enrollment
85
Phase
PHASE2
Primary Completion Date
2011-09
Status
COMPLETED
relationships
The graph out of here
drug
1-hertz Repetitive Transcranial Magnetic Stimulation
drug
Active 1-Hertz Repetitive transcranial magnetic stimulation
drug
lead_sponsor
Yale University
company
collaborator
National Institute of Mental Health (NIMH)
company
indication
Hallucinations
indication
Hallucinations
indication
Psychotic Disorders
indication
investigator
Ralph E. Hoffman, MD
person